The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Motorized Linear Rail Assembly Combines Motion Technologies

July 8, 2010 6:19 am | Haydon Kerk Motion Solutions | Product Releases | Comments

Haydon Kerk Motion Solutions, a leading manufacturer of engineered linear motion products, offers the dual carriage RGS04 motorized linear rail assembly. This system combines many of Haydon Kerk’s patented motion technologies into a single integrated system.

Epoxy Packaging Is Well Suited for Small Applications

July 8, 2010 6:04 am | Adhesive Packaging Specialties, Inc. | Product Releases | Comments

Packaging for reactive adhesives, sealants, or resins in small two-part epoxy delivery systems requires only a minimal amount of material to be dispensed at one time.

Lantheus resigns with MDS Nordion; supplies to resume once AECL reactor restarts

July 8, 2010 5:45 am | by The Associated Press | News | Comments

Canada's leading nuclear medicine company is gearing up for the restart of Atomic Energy of Canada's aging reactor in Chalk River, Ont.MDS Nordion, which now forms the core of Canadian life-science company MDS Inc. (TSX:MDS), says it has a new contract with its primary customer.Nordion will...


House strikes gift ban in effort to boost business

July 8, 2010 5:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Reversing course on a new law aimed at diminishing the influence on doctors of pharmaceutical and medical device companies, the House on Wednesday voted to strike the so-called gift ban law, which critics say has hurt commerce in the medical and restaurant industries.


US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others

July 8, 2010 5:37 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS , July 8 /- Protectus Medical Devices, Inc. (OTCQB: PTMD), developer and marketer of innovative safety medical devices, announced today it has received Notice of Allowance from the US Patent and Trademark Office on its patent application describing a spring-activated,...


Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States

July 8, 2010 5:37 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM , July 8 /- Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United...


New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets

July 8, 2010 5:36 am | by Bio-Medicine.Org | News | Comments

DALLAS , July 8, 2010 /- According to a new market research report, 'Emerging Markets BRIC ( Brazil , Russia , India and China ) Patient Monitoring Market (2010 - 2015), published by MarketsandMarkets ( ), the total BRIC patient monitoring devices market...


Simple diagnostic tool predicts Type 2 diabetes in Southeast Asians

July 8, 2010 5:35 am | by EurekAlert | News | Comments

(Research Australia) Australian and Vietnamese researchers have estimated the current prevalence of Type 2 diabetes in Vietnam, and have developed a simple tool for identifying individuals at high risk.Often triggered by sedentary lifestyles and high-fat or high-sugar diets,...


Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies

July 8, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

WATERLOO, Belgium , July 8, 2010 /- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R)...


Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial

July 8, 2010 5:35 am | by Boston Scientific | News | Comments

NATICK, Mass., July 8 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in its MultiSENSE clinical trial. The trial is designed to evaluate multiple physiolog


Guidance for HDE Holders, Institutional Review Boards (IRBs), Clinical Investigators, and Food and Drug Administration Staff - Humanitarian Device Exemption (HDE) Regulation: ...

July 8, 2010 5:32 am | by U.S. Food & Drug Administration | News | Comments

This guidance document answers commonly asked questions about Humanitarian Use Devices (HUDs) and applications for Humanitarian Device Exemption (HDE) authorized by section 510(m)(2) of the Federal Food, Drug, and Cosmetic Act (the Act). This guidance doc


Alcon starts lawsuit trust, focuses on Novartis

July 8, 2010 2:45 am | by The Associated Press | News | Comments

Alcon Inc.'s Independent Director Committee said Thursday it created a litigation trust with $50 million for litigation related to any deal between Alcon and a majority shareholder, with a focus on Novartis.The trust was formed to provide funds to commence, defend or maintain a lawsuit....

Michael Garippa Joins SynCardia as President

July 8, 2010 12:34 am | by SynCardia | News | Comments

SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Michael Garippa, the CEO and President of TandemHeart for the last 8 years, has left the company to become SynCardia's new president. Rodger Ford will continue as SynCardia's CEO,...


1 in 4 Californian children have never seen a dentist, study finds

July 7, 2010 10:42 pm | by EurekAlert | News | Comments

(University of California - Los Angeles) A new UCLA Center for Health Policy Research study published in the July issue of Health Affairs reveals that in California, nearly 25 percent of children in the state have never seen a dentist and that disparities exist across race,...


Startup Aims to Bring Useless Farmland Back to Life

July 7, 2010 10:41 pm | by Massachusetts Institute of Technology | News | Comments

The company is developing crops that tolerate salty soils.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.